Mesothelioma Legal News

Annual CT Scan Recommended for Heavy Smokers By Preventive Task Force

Health Advocates Push to Broaden At Risk Population to Include Asbestos Victims, Individuals Predisposed to Lung Cancer

Baron and Budd Applauds the Development of a New Drug for the Treatment of Mesothelioma

Known as VS-6063, or defactinib, this cancer-stem-cell inhibitor manufactured by Verastem Inc. was given orphan drug designation by the FDA for treatment of mesothelioma.Source: www.topix.com Via newsmixx: home News